Trials / Sponsors / Xinnate AB
Xinnate AB
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study Epidermolysis Bullosa (EB), Dystrophic Epidermolysis Bullosa, Junctional Epidermolysis Bullosa | Phase 2 | 2026-01-30 |
| Completed | Safety, Tolerability, and Pharmacokinetics of Ascending Topical Doses of TCP-25 Applied to Epidermal Suction B Blister, Wound of Skin, Epidermolysis Bullosa | Phase 1 | 2022-04-07 |